The global biopsy forceps Market is entering a sustained growth phase as diagnostic endoscopy volumes rise and healthcare systems worldwide expand cancer screening infrastructure. According to a report from Business Market Insights, the biopsy forceps market was valued at US$ 0.8 billion in 2025 and is projected to reach US$ 1.64 billion by 2033, growing at a CAGR of 9.39% during 2026–2033, driven by rising cancer screening programs, increasing adoption of minimally invasive diagnostic procedures, and expanding endoscopy volumes, while outpatient diagnostics, healthcare technology advancements, and specialized procedure expansion create significant growth opportunities.
Grab the sample report @ https://www.businessmarketinsights.com/sample/BMIPUB00036374
What’s Fueling the Growth
Three interconnected forces are driving this market’s expansion. The global rise in screening programs for colorectal, stomach, lung, and cervical cancers continues to push up the number of cases requiring minimally invasive tissue sampling, as healthcare systems increasingly recognize that early detection improves patient outcomes while reducing long-term treatment costs.
Alongside this, the broader shift toward minimally invasive procedures is reshaping clinical practice. Physicians are increasingly favoring techniques that shorten recovery times and improve outcomes, which in turn is driving demand for more maneuverable biopsy devices compatible with advanced flexible endoscope systems. Finally, rising rates of gastrointestinal, respiratory, urological, and gynecological disorders — compounded by aging populations and expanding healthcare access — are steadily increasing the volume of diagnostic endoscopy procedures performed each year, sustaining consistent demand for biopsy instruments.
Market Segmentation
The report segments the market across four dimensions: product type, usability, application, and end-user. By product type — flexible and rigid biopsy forceps — flexible forceps dominate the market, reflecting their compatibility with modern flexible endoscopy systems and their superior maneuverability for reaching complex anatomical sites.
On usability, the market splits between disposable and reusable devices, with disposable forceps representing the fastest-growing category as hospitals and ambulatory surgery centers prioritize infection prevention and eliminate the costs and risks associated with device reprocessing.
By application — gastrointestinal endoscopy, bronchoscopy, urology, gynecology, laparoscopy, ENT, and others — gastrointestinal endoscopy leads the segment, propelled by colorectal cancer screening initiatives and rising diagnosis of inflammatory bowel disease. Bronchoscopy applications are also expanding steadily alongside growing lung cancer screening programs.
Finally, by end-user — hospitals & ASCs, specialty clinics, diagnostic/endoscopy centers, and others — hospitals and ambulatory surgical centers account for the largest share, supported by high patient volumes and continued investment in advanced endoscopy equipment, while independent diagnostic centers are expanding their service offerings through modern endoscopy platform investments.
Regional Outlook
North America leads the global market, underpinned by high endoscopy procedure volumes, strong reimbursement systems, and widespread adoption of advanced minimally invasive technologies, with the United States driving regional demand through expanding gastrointestinal and pulmonary diagnostic activity.
Asia Pacific is projected to post the fastest growth through 2033, fueled by expanding healthcare infrastructure, rising cancer awareness campaigns, and growing access to minimally invasive diagnostics. China leads regional demand through substantial healthcare investment and hospital expansion, while India is expected to post the highest regional growth rate as medical infrastructure and healthcare expenditure continue to rise.
Europe holds a solid position in the global market, supported by strong public healthcare systems and expanding cancer screening initiatives, with Germany maintaining regional leadership while Spain posts one of the fastest growth rates. The Rest of World region — spanning South & Central America and the Middle East & Africa — continues to grow steadily, with Brazil leading regional demand and Saudi Arabia recording the fastest projected growth as healthcare transformation initiatives accelerate.
Opportunities and Challenges
Looking forward, the rapid expansion of ambulatory surgery centers, specialty clinics, and outpatient diagnostic facilities presents a major opportunity, as healthcare systems increasingly favor minimally invasive approaches that reduce hospitalization costs and improve patient comfort. Advances in high-resolution endoscopy, robotic assistance, and AI-enabled lesion identification are also creating room for next-generation biopsy forceps with improved ergonomics and more precise tissue-sampling capabilities. Additionally, the growing use of sophisticated endoscopic techniques across pulmonology, gastroenterology, urology, gynecology, and ENT continues to expand commercial opportunities for specialized, high-precision devices.
That said, the industry faces meaningful hurdles. Biopsy forceps must meet rigorous regulatory requirements, including clinical validation and biocompatibility testing, before commercial approval — a process that extends development timelines and raises costs, potentially delaying the introduction of innovative technologies. Developing advanced forceps also demands precision engineering and extensive clinical evaluation, creating high barriers to entry for smaller manufacturers and intensifying pricing pressure across an already competitive medical device landscape.
Competitive Landscape
The market is shaped by established medical device leaders including Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Cook Medical, CONMED Corporation, Integra LifeSciences Holdings Corporation, Cardinal Health, Inc., B. Braun Melsungen AG, STERIS plc, and Endo-Flex GmbH. These companies continue to invest in ergonomic device design, expanding disposable product lines, and strategic collaborations with healthcare providers to strengthen their global reach. Recent developments — including a major GI product line acquisition, new single-use fine needle biopsy device launches across the US, Europe, and Japan, and FDA clearance for an updated pulmonary biopsy forceps — highlight the pace of innovation shaping this competitive landscape.
Buy Report Now @ https://www.businessmarketinsights.com/buy/BMIPUB00036374
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Ankit Mathur
Email: sales@businessmarketinsights.com
Phone: +16467917070
